Outcomes Following Biochemical or Clinical Progression in Patients with Multiple Myeloma

被引：1
|
作者：
Goldman-Mazur, Sarah [1 ]
Visram, Alissa [1 ,2 ]
Rajkumar, S. Vincent [1 ]
Kapoor, Prashant [1 ]
Dispenzieri, Angela [1 ]
Lacy, Martha Q. [1 ]
Gertz, Morie A. [1 ]
Buadi, Francis K. [1 ]
Hayman, Suzanne R. [1 ]
Dingli, David [1 ]
Kourelis, Taxiarchis [1 ]
Gonsalves, Wilson I. [1 ]
Warsame, Rahma M. [1 ]
Muchtar, Eli [1 ]
Leung, Nelson [1 ]
Kyle, Robert A. [1 ]
Kumar, Shaji [3 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Ottawa Hosp Res Inst, Div Hematol, Ottawa, ON, Canada
[3] Mayo Clin, Dept Hematol, Rochester, MN USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149339
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3760
引用
收藏
页码：3760 / +
页数：6
相关论文
共 50 条
  • [41] Radiologic Progression of Vertebral Fractures in Patients with Multiple Myeloma
    Xiao, Roy
    Miller, Jacob
    Featherall, Joseph
    Lubelski, Daniel
    Benzel, Edward
    Mroz, Thomas
    [J]. JOURNAL OF NEUROSURGERY, 2015, 123 (02) : A483 - A483
  • [42] Salvage therapies and clinical outcomes after relapse following BCMA CAR-T in patients with relapsed/refractory multiple myeloma
    Reyes, Kevin
    Liu, Yen-Chun
    Huang, Chiung-Yu
    Banerjee, Rahul
    Martin, Thomas
    Shah, Nina
    Wong, Sandy
    Wolf, Jeffrey
    Arora, Shagun
    Chung, Alfred
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S31 - S32
  • [43] Quality of Life and Outcomes in Multiple Myeloma Patients
    Paul, Shilpa
    Kochuparambil, Samith T.
    Thompson, Carrie A.
    Shanafelt, Tait D.
    Buadi, Francis K.
    Lacy, Martha Q.
    Gertz, Morie A.
    Dispenzieri, Angela
    Dingli, David
    Kapoor, Prashant
    Hayman, Suzanne R.
    Hwa, Lisa
    Case, Jane K.
    Rajkumar, Vincent
    Kumar, Shaji
    [J]. BLOOD, 2014, 124 (21)
  • [44] Outcomes of sepsis in patients with multiple myeloma.
    Moturi, Krishna Rekha
    Lingamaneni, Prasanth
    Vohra, Ishaan
    Baral, Binav
    Farooq, Muhammad Zain
    Batra, Kunnal
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [45] Clinical utility of biochemical markers of bone metabolism for improving the management of patients with advanced multiple myeloma
    Lipton, Allan
    Cook, Richard J.
    Coleman, Robert E.
    Smith, Matthew R.
    Major, Pierre
    Terpos, Evangelos
    Berenson, James R.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (05): : 346 - 353
  • [46] Kidney Transplant Outcomes of Patients With Multiple Myeloma
    Heybeli, Cihan
    Bentall, Andrew J.
    Alexander, Mariam Priya
    Amer, Hatem
    Buadi, Francis K.
    Dispenzieri, Angela
    Dingli, David
    Gertz, Morie A.
    Issa, Naim
    Kapoor, Prashant
    Kukla, Aleksandra
    Kumar, Shaji
    Lorenz, Elizabeth C.
    Rajkumar, S. Vincent
    Schinstock, Carrie A.
    Leung, Nelson
    [J]. KIDNEY INTERNATIONAL REPORTS, 2022, 7 (04): : 752 - 762
  • [47] Clinical progression of multiple myeloma presenting as parotid gland plasmacytoma
    Goyal, Hemant
    Sawhney, Harinder
    Abdu, Afaf
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 297 - 298
  • [48] Clinical progression of multiple myeloma presenting as parotid gland plasmacytoma
    Hemant Goyal
    Harinder Sawhney
    Afaf Abdu
    [J]. International Journal of Hematology, 2013, 97 : 297 - 298
  • [49] Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
    Zhang, Liuyun
    Xiang, Yunhui
    Li, Yanying
    Zhang, Juan
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [50] Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other clinical parameters in untreated multiple myeloma patients
    Alexandrakis, MG
    Passam, FH
    Malliaraki, N
    Katachanakis, C
    Kyriakou, DS
    Margioris, AN
    [J]. CLINICA CHIMICA ACTA, 2002, 325 (1-2) : 51 - 57
12345